Researchers argue that, in some situations where machine-learning models are used to allocate scarce resources or opportunities, randomizing decisions in a structured way may lead to fairer outcomes.

Longer times from symptom onset to randomization equaled a smaller—or perhaps no—advantage for Impella vs standard care.